cardiovascular disease

Pfizer spies cardiovascular potential in Riparian preclinical licensing agreement
Fierce Biotech
Wed, 07/19/23 - 06:02 pm
Pfizer
Riparian Pharmaceuticals
cardiovascular disease
Novartis Culls 10% of Pipeline, Doubles Down on Five Core Therapeutic Areas
BioSpace
Wed, 04/26/23 - 10:24 am
Novartis
earnings
solid tumors
hematology
immunology
Neuroscience
cardiovascular disease
Ionis announces enrollment completion of Phase 3 Lp(a) HORIZON cardiovascular outcomes study of pelacarsen
Yahoo Finance
Wed, 07/20/22 - 09:31 am
Ionis Pharmaceuticals
clinical trials
cardiovascular disease
pelacarsen
Novartis turns to algorithms developer Anumana to apply AI to cardio conditions
MedCity News
Sun, 07/17/22 - 10:41 pm
Novartis
Anumana
artificial intelligence
diagnostics
cardiovascular disease
Cytokinetics aims to become the Vertex of cardiovascular disease
EP Vantage
Thu, 06/16/22 - 10:19 am
Cytokinetics
Amgen
heart failure
Omecamtiv Mecarbil
cardiovascular disease
Amgen eyes swift move to ph3 for cardiovascular drug olpasiran
Pharmaforum
Wed, 06/1/22 - 09:33 am
Amgen
olpasiran
Novartis
clinical trials
cardiovascular disease
Merck looks to cardiovascular pipeline for $10B+ peak sales—and diversification from Keytruda
Fierce Biotech
Tue, 04/5/22 - 11:36 pm
Merck
Keytruda
cardiovascular disease
Bayer, One Drop launch AI tool for heart disease prevention
Pharmaforum
Wed, 10/27/21 - 11:39 pm
Bayer
One Drop
digital health
artificial intelligence
cardiovascular disease
7 Moments in 2021 Destined to Change the Cardio-Device Industry Forever
Medical Devices and Diagnostics Industry
Sat, 06/12/21 - 10:29 pm
devices
cardiovascular disease
Medtronic
LivaNova
Google
AliveCor
Abbott Labs
Elucid Raises $8M in Series A Round During the ‘Zoom Era’
Medical Devices and Diagnostics Industry
Mon, 05/10/21 - 09:27 pm
diagnostics
ElucidVivo
artificial intelligence
cardiovascular disease
Bayer's near-approval Farxiga rival meets goal in 2nd phase 3
Fierce Biotech
Mon, 05/10/21 - 10:03 am
Bayer
finerenone
Farxiga
clinical trials
cardiovascular disease
myocardial infarction
Heart disease devices lead latest batch of FDA breakthrough nods
Medtech Dive
Wed, 02/10/21 - 10:19 am
devices
FDA
cardiovascular disease
Roche
Puzzle Medical Devices
Alleviant Medical
Pedra Technology
Vascular Perfusion Solutions
A much-hyped CV drug failed, repeatedly. Now, investors are betting nearly $200M on one last PhIII bid
Endpoints
Thu, 01/14/21 - 10:45 am
Eli Lilly
cardiovascular disease
NewAmsterdam Pharma
CETP inhibitors
Amgen and Cytokinetics claim heart drug success, but results widely disappoint
BioPharma Dive
Thu, 10/8/20 - 11:19 pm
Amgen
Cytokinetics
Servier
clinical trials
Omecamtiv Mecarbil
cardiovascular disease
Heart to heart: Novo Nordisk teams with ACC to open diabetes discussion
Fierce Pharma
Mon, 09/28/20 - 10:39 am
Novo Nordisk
pharma marketing
American College of Cardiology
patients
cardiovascular disease
Highlights: 2020 Cardiometabolic Health Congress West Live Online
CP WIre
Fri, 08/21/20 - 12:10 pm
cardiometabolic health
cardiovascular disease
obesity
Silence Therapeutics Says Collaborating With Astrazeneca On siRNA Therapeutics
Reuters
Wed, 03/25/20 - 10:34 am
Silence Therapeutics
AstraZeneca
siRNA
drug development
cardiovascular disease
renal disease
respiratory disease
metabolic disorders
Novartis eyes Medicines Co to boost cardio franchise - report
Yahoo/Reuters
Tue, 11/19/19 - 10:18 am
Novartis
The Medicines Company
cardiovascular disease
M&A
AstraZeneca's diabetes drug Farxiga helps patients with heart disease and without diabetes in landmark trial
Endpoints
Tue, 08/20/19 - 10:28 am
AstraZeneca
Farxiga
cardiovascular disease
Bayer teams up with AI firm Sensyne Health to mine NHS data for its heart disease pipeline
Fierce Biotech
Wed, 07/31/19 - 11:52 pm
Bayer
UK
Sensyne Health
artificial intelligence
cardiovascular disease

Pages